Info

What2Know - a Marketing and Communications Podcast

The What 2 Know podcast explores best practices, innovation and latest trends with industry experts with an eye toward helping you, the listener, stay ahead of the ever changing marketing and communications landscape.
RSS Feed Subscribe in Apple Podcasts
What2Know - a Marketing and Communications Podcast
2019
October
September
August
July
June
May
April
March
February
January


2018
December
November
October
September
August
July
June
May
April
March
February
January


2017
December
November
October
September
August
July
June
May
April
March
February


Categories

All Episodes
Archives
Categories
Now displaying: September, 2017
Sep 29, 2017

Leveraging social media and technology has proven to be highly impactful for the culinary industry. Erik Murnighan, President of The International Culinary Center chats about the plethora of ways food has benefited from the evolution of tech & social.

Sep 21, 2017

Kim L. Hunter (Founder & Managing Partner of KLH & Associates + President & CEO of LAGRANT COMMUNICATIONS) noticed a major issue in our industry and decided to do something about it. Kim is also the founder & CEO of the LAGRANT Foundation, an org. that addresses the lack of diversity in the advertising, marketing and public relations fields. He shares how prioritizing diversity strengthens organizations and enables stronger ideas for clients.

Sep 14, 2017

Digital has forced every industry to adapt, change and innovate. From automotive to music, corporations are being pushed to be creative like never before. This week’s guest, Jeremiah Owyang, Founder of Crowd Companies, discusses how top organizations are operationalizing innovation and what steps companies need to take in order to ensure they are not left behind.

Sep 7, 2017

The use of data, technology and life sciences have proven to essential to the fight against cancer. This week Aaron Strout chats with John Hinshaw, Board Member of DocuSign, The Bank of New York Mellon, and the National Academy Foundation and John A. Orwin, Board Member of Seattle Genetics, Retrophin, and Array BioPharma to discuss this balancing act.

1